Teng Ai

738 total citations
22 papers, 624 citations indexed

About

Teng Ai is a scholar working on Organic Chemistry, Molecular Biology and Geriatrics and Gerontology. According to data from OpenAlex, Teng Ai has authored 22 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 13 papers in Molecular Biology and 5 papers in Geriatrics and Gerontology. Recurrent topics in Teng Ai's work include Chemical Synthesis and Analysis (9 papers), Synthesis and Catalytic Reactions (8 papers) and Asymmetric Synthesis and Catalysis (7 papers). Teng Ai is often cited by papers focused on Chemical Synthesis and Analysis (9 papers), Synthesis and Catalytic Reactions (8 papers) and Asymmetric Synthesis and Catalysis (7 papers). Teng Ai collaborates with scholars based in United States, China and Saudi Arabia. Teng Ai's co-authors include Guigen Li, Liqiang Chen, Yanli Xü, Daniel J. Wilson, Min Shi, Jianlin Han, Swati S. More, Parminder Kaur, Li Qiu and Huaqing Cui and has published in prestigious journals such as Molecular Cell, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Teng Ai

21 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teng Ai United States 15 397 252 116 88 80 22 624
Kenneth Keavey United Kingdom 5 154 0.4× 239 0.9× 273 2.4× 146 1.7× 22 0.3× 6 576
Jeremy S. Disch United States 8 121 0.3× 134 0.5× 218 1.9× 92 1.0× 15 0.2× 9 425
Maria Fridén‐Saxin Sweden 10 343 0.9× 127 0.5× 61 0.5× 24 0.3× 23 0.3× 12 495
Michael J. Kates United States 7 166 0.4× 206 0.8× 271 2.3× 132 1.5× 7 0.1× 8 551
Esther Torrente Spain 10 230 0.6× 92 0.4× 13 0.1× 93 1.1× 20 0.3× 20 432
Xiaozhang Zheng United States 13 102 0.3× 249 1.0× 85 0.7× 31 0.4× 7 0.1× 26 448
Veit Wascholowski Germany 9 217 0.5× 392 1.6× 21 0.2× 19 0.2× 33 0.4× 13 537
Niefang Yu China 9 206 0.5× 142 0.6× 23 0.2× 11 0.1× 18 0.2× 13 346
Branko Radetich United States 9 324 0.8× 227 0.9× 5 0.0× 50 0.6× 113 1.4× 10 526
Junya Ishida Japan 12 196 0.5× 236 0.9× 9 0.1× 16 0.2× 42 0.5× 16 552

Countries citing papers authored by Teng Ai

Since Specialization
Citations

This map shows the geographic impact of Teng Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teng Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teng Ai more than expected).

Fields of papers citing papers by Teng Ai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teng Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teng Ai. The network helps show where Teng Ai may publish in the future.

Co-authorship network of co-authors of Teng Ai

This figure shows the co-authorship network connecting the top 25 collaborators of Teng Ai. A scholar is included among the top collaborators of Teng Ai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teng Ai. Teng Ai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ai, Teng, Daniel J. Wilson, & Liqiang Chen. (2023). 5-((3-Amidobenzyl)oxy)nicotinamides as SIRT2 Inhibitors: A Study of Constrained Analogs. Molecules. 28(22). 7655–7655. 4 indexed citations
2.
Iizuka, Yoshie, Qing Yang, Courtney Coombes, et al.. (2018). UNC-45A Is a Novel Microtubule-Associated Protein and Regulator of Paclitaxel Sensitivity in Ovarian Cancer Cells. Molecular Cancer Research. 17(2). 370–383. 14 indexed citations
3.
Ai, Teng, Rose Willett, J.M. Williams, et al.. (2016). N-(1-Benzyl-3,5-dimethyl-1H-pyrazol-4-yl)benzamides: Antiproliferative Activity and Effects on mTORC1 and Autophagy. ACS Medicinal Chemistry Letters. 8(1). 90–95. 12 indexed citations
4.
Kim, Kwan‐Hyun, Barbara R. Tschida, Zohar Sachs, et al.. (2016). mTORC1 Coordinates Protein Synthesis and Immunoproteasome Formation via PRAS40 to Prevent Accumulation of Protein Stress. Molecular Cell. 61(4). 625–639. 56 indexed citations
5.
Ai, Teng, Daniel J. Wilson, Swati S. More, Jiashu Xie, & Liqiang Chen. (2016). 5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors. Journal of Medicinal Chemistry. 59(7). 2928–2941. 30 indexed citations
6.
Alhazzazi, Turki Y., Pachiyappan Kamarajan, Yanli Xü, et al.. (2016). A Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer Cells.. PubMed. 36(1). 49–60. 48 indexed citations
7.
Ai, Teng, Li Qiu, Jiashu Xie, Robert J. Geraghty, & Liqiang Chen. (2015). Design and synthesis of an activity-based protein profiling probe derived from cinnamic hydroxamic acid. Bioorganic & Medicinal Chemistry. 24(4). 686–692. 8 indexed citations
8.
Ai, Teng, Yanli Xü, Li Qiu, Robert J. Geraghty, & Liqiang Chen. (2014). Hydroxamic Acids Block Replication of Hepatitis C Virus. Journal of Medicinal Chemistry. 58(2). 785–800. 42 indexed citations
9.
Cui, Huaqing, Teng Ai, Yanli Xü, et al.. (2014). Discovery of Potent and Selective Sirtuin 2 (SIRT2) Inhibitors Using a Fragment-Based Approach. Journal of Medicinal Chemistry. 57(20). 8340–8357. 70 indexed citations
10.
Ai, Teng. (2013). Analysis of Deformation in Widening Project of Expressway by Finite Element Method. Advanced materials research. 717. 290–294. 2 indexed citations
11.
Kattamuri, Padmanabha V., Teng Ai, Suresh Pindi, et al.. (2011). Asymmetric Synthesis of α-Amino-1,3-dithianes via Chiral N-Phosphonyl Imine-Based Umpolung Reaction Without Using Chromatography and Recrystallization. The Journal of Organic Chemistry. 76(8). 2792–2797. 35 indexed citations
12.
Ai, Teng, Suresh Pindi, Padmanabha V. Kattamuri, & Guigen Li. (2010). Chiral N-phosphonyl imine chemistry: asymmetric additions of glycine enolate to diphenyl diamine-based phosphonyl imines. Science China Chemistry. 53(1). 125–129. 14 indexed citations
13.
Ai, Teng, Jianlin Han, Zhong‐Xiu Chen, & Guigen Li. (2009). Chiral N‐Phosphonyl Imine Chemistry: Asymmetric Synthesis of α‐Alkyl β‐Amino Ketones by Reacting Phosphonyl Imines with Ketone‐Derived Enolates. Chemical Biology & Drug Design. 73(2). 203–208. 27 indexed citations
14.
Ai, Teng & Guigen Li. (2009). Chiral N-phosphonyl imine chemistry: Asymmetric synthesis of α,β-diamino esters by reacting phosphonyl imines with glycine enolates. Bioorganic & Medicinal Chemistry Letters. 19(14). 3967–3969. 28 indexed citations
15.
Han, Jianlin, et al.. (2008). Chiral N‐Phosphonyl Imine Chemistry: Asymmetric Additions of Ester Enolates for the Synthesis of β‐Amino Acids. Chemical Biology & Drug Design. 72(2). 120–126. 32 indexed citations
16.
Kaur, Parminder, et al.. (2008). Chiral N‐Phosphonyl Imine Chemistry: Asymmetric Aza‐Henry Reaction. Chemical Biology & Drug Design. 71(3). 216–223. 39 indexed citations
18.
Li, Guigen, Jianlin Han, & Teng Ai. (2008). ChiralN-Phosphonyl Imine Chemistry: Asymmetric Addition of Ketone-Derived Enolates for the Synthesis of β-Amino Ketones. Synthesis. 2008(16). 2519–2526. 6 indexed citations
19.
Ai, Teng, et al.. (2007). Asymmetric catalytic aza-Morita–Baylis–Hillman reaction using chiral bifunctional phosphine amides as catalysts. Tetrahedron. 64(7). 1181–1186. 51 indexed citations
20.
Ai, Teng, et al.. (2007). Chelation-controlled asymmetric aminohalogenation reaction. Tetrahedron Letters. 48(44). 7894–7898. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026